Literature DB >> 16952275

RNA-interference effectors and their delivery.

D Putnam1, A Doody.   

Abstract

RNA-interference, the mechanism by which the expression of a specific protein can be reduced or eliminated, has emerged as a potential way to treat disease. RNA-interference effectors, such as small interfering RNA and small hairpin RNA, are double-stranded nucleic acid sequences expressly designed to have homology to sections of the target protein's mRNA, and when present in the cytosol trigger hydrolysis of the mRNA through the RNA-interference pathway. Because RNA-interference effectors are macromolecular and typically polyanionic, their efficacy is poor when not accompanied by a delivery vehicle. This review outlines the RNA-interference mechanism and discusses the delivery of RNA-interference effectors, with an emphasis on synthetic polymer-based delivery systems.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16952275     DOI: 10.1615/critrevtherdrugcarriersyst.v23.i2.30

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  8 in total

Review 1.  Matrices and scaffolds for DNA delivery in tissue engineering.

Authors:  Laura De Laporte; Lonnie D Shea
Journal:  Adv Drug Deliv Rev       Date:  2007-04-14       Impact factor: 15.470

2.  A combinatorial library of bi-functional polymeric vectors for siRNA delivery in vitro.

Authors:  Jeisa M Pelet; David Putnam
Journal:  Pharm Res       Date:  2012-09-28       Impact factor: 4.200

3.  CABYR RNAi plasmid construction and NF-κB signal transduction pathway.

Authors:  Lin-Xiang Shi; Yao-Ming He; Lin Fang; Hong-Bo Meng; Li-Jun Zheng
Journal:  World J Gastroenterol       Date:  2010-10-21       Impact factor: 5.742

4.  Very long chain N4, N9 -diacyl spermines: non-viral lipopolyamine vectors for efficient plasmid DNA and siRNA delivery.

Authors:  Hassan M Ghonaim; Shi Li; Ian S Blagbrough
Journal:  Pharm Res       Date:  2008-09-10       Impact factor: 4.200

5.  N1,N12-Diacyl spermines: SAR studies on non-viral lipopolyamine vectors for plasmid DNA and siRNA formulation.

Authors:  Hassan M Ghonaim; Shi Li; Ian S Blagbrough
Journal:  Pharm Res       Date:  2009-10-30       Impact factor: 4.200

Review 6.  Self-assembling materials for therapeutic delivery.

Authors:  Monica C Branco; Joel P Schneider
Journal:  Acta Biomater       Date:  2008-10-10       Impact factor: 8.947

7.  Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer.

Authors:  Maha Saad; Olga B Garbuzenko; Tamara Minko
Journal:  Nanomedicine (Lond)       Date:  2008-12       Impact factor: 5.307

Review 8.  Nanoparticles Targeting STATs in Cancer Therapy.

Authors:  Milad Ashrafizadeh; Zahra Ahmadi; Niranjan G Kotla; Elham Ghasemipour Afshar; Saeed Samarghandian; Ali Mandegary; Abbas Pardakhty; Reza Mohammadinejad; Gautam Sethi
Journal:  Cells       Date:  2019-09-27       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.